Sunday, July 5, 2020
Home Life Style Health & Fitness Drug Used For Osteoporosis May Help in Reducing Heart Attack Risk

Drug Used For Osteoporosis May Help in Reducing Heart Attack Risk

Intake of the drug also reduced the risk of stroke by 18 per cent within five years and 17 per cent within 10 years.

A commonly used drug for treating osteoporosis or bone pain may also help reduce the risk of death by cardiovascular, heart attack and stroke, according to a study.

The report, published in Journal of Bone and Mineral Research, showed that the drug Alendronate could lower the risk of cardiovascular diseases by 67 per cent and heart attacks by 45 per cent within a year.

Intake of the drug also reduced the risk of stroke by 18 per cent within five years and 17 per cent within 10 years.

“Our findings show that Alendronate is potentially cardioprotective in hip fracture patients,” said Ching-Lung Cheung, from the University of Hong Kong.

“Physicians should consider prescribing Alendronate or other similar drugs to patients with hip fracture and patients should also have good compliance with Alendronate treatment, as this is not only good for your bones but also your heart,” Cheung added.

It is used for osteoporosis, osteogenesis imperfecta, and several other bone diseases.
Spine Bones, Pixabay

Alendronate belongs to a class of drugs called bisphosphonates and works by preventing bone breakdown and increasing bone density.

It is used for osteoporosis, osteogenesis imperfecta, and several other bone diseases.

The researchers collected data from 34,991 patients, diagnosed with hip fracture in 2005. Out of these 4,602 patients received osteoporosis treatment during follow up.

Also Read: Healthy Diet May Decrease the Risk of Hearing Loss in Women 

Due to excess cardiovascular adverse events, there is a worldwide crisis in the current treatment of osteoporosis with drug romosozumab.

In 2017, the US Food and Drug Administration (FDA) had rejected romosozumab and requested more data before reaching a decision.

The study, thus, has significant implications in clinical trial design of anti-osteoporosis medications, the researchers said. (IANS)

STAY CONNECTED

18,999FansLike
362FollowersFollow
1,779FollowersFollow

Most Popular

Oats, Rye Brans Intake May Reduce Hepatic Inflammation, Weight Gain

Want to lose some weight? Read on. Researchers have found that the consumption of dietary fibre from oat and rye brans increased the growth...

Women-centric development will guide the Atmanirbhar Bharat: BJP Leader

Senior BJP leader and member of Parliament from Sirsa in Haryana, Sunita Duggal, said on Sunday that women-centric development will guide the Atmanirbhar Bharat...

Women Experiencing Hot Flushes, Night Sweats Likely to Get Heart Attacks

Women who suffer from hot flushes and night sweats after menopause are 70 per cent more likely to have a heart attack, angina or...

Film-TV Body Discusses Issue of Senior Actors’ Shoot With Maharashtra Governor

Cine And TV Artistes' Association (CINTAA) Senior Vice President, actor Manoj Joshi, held a meeting with Maharashtra Governor Bhagat Singh Koshyari on Saturday to...

Former Police Officer Wishes Ayushmann, Rajkummar or Vicky to Play Him On Screen

Now that his book "The Barabanki Narcos: Busting Indias Most Notorious Drug Cartel" is set to be made into a web series, former police...

Endangered Rare Orchid Plant Found in Dudhwa National Park, UP

A rare orchid plant variety, categorised as an 'endangered species', has been found in the Dudhwa National Park in Uttar Pradesh. Popularly known as Ground...

62% Americans no Longer View US as a ‘Shining City on The Hill’

A new poll has found that 62 per cent of Americans no longer view the US as a "shining city on the hill" as...

Users Complain of Spam Emails as Gmail Suffers From Filtering Issues

Gmail users around the world were complaining about spam messages flooding their inbox over the weekend as the Google service was apparently suffering from...

Recent Comments